Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong

Cancer Investigation

Volumn 26, Issue 2, 2008, Pages 128-135

  Au, Joseph S K ^a   Cho, William C S ^a   Yip, Tai Tung ^b   Law, Stephen C K ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

Author keywords

Cancer Biomarkers; Lung Cancer; Protein Profiling

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CANCER TISSUE; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HONG KONG; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG PARENCHYMA; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; STATISTICAL SIGNIFICANCE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADENOCARCINOMA; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; COMPUTATIONAL BIOLOGY; FEMALE; HONG KONG; HUMANS; LUNG NEOPLASMS; MALE; PROTEIN ARRAY ANALYSIS; PROTEOME; PROTEOMICS; SMOKING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 38949178766     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701788031     Document Type: Article

References (15)

1. Parkin, D.M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74-108.
2. Au, J. S.; Mang, O.W.; Foo, W.; Law, S.C. Time trends of lung cancer incidence by histologic types and smoking prevalence in Hong Kong 1983-2000. Lung Cancer 2004, 45, 143-152.
3. I.T. Yu, Y.L. Chiu, J.S. Au, T.W. Wong, J.L. Tang, Dose-response relationship between cooking fumes exposures and lung cancer among Chinese nonsmoking women, Cancer Res. 2006, 66, 4961-4967.
4. W.C. Cho, Contribution of oncoproteomics to cancer biomarker discovery, Mol. Cancer 2007, 6, 25.
5. W.C. Cho, Research progress in SELDI-TOF MS and its clinical applications, Chin. J. Biotech. 2006, 22 , 871-876.
6. W.C. Cho, T.T. Yip, W.S. Chung, A.W. Leung, C.H. Cheng, K.K. Yue, Potential biomarkers found by proteomic profiling may provide insight for the macrovascular pathogenesis of diabetes mellitus, Dis. Markers 2006, 22, 153-166.
7. W.C. Cho, T.T. Yip, C. Yip, V. Yip, V. Thulasiraman, R.K. Ngan, T.T. Yip, W.H. Lau, J.S. Au, S.C. Law, W.W. Cheng, V.W. Ma, C.K. Lim, Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling, Clin. Cancer Res. 2004, 10, 43-52.
8. W.C. Cho, T.T. Yip, R.K. Ngan, T.T. Yip, V.N. Podust, C. Yip, H.H. Yiu, V. Yip, W.W. Cheng, V.W. Ma, S.C. Law, Proteinchip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma, Clin. Chem. 2007, 53, 241-250.
9. J. Whitney, Testing for differences with the nonparametric Mann-Whitney U test, J. Wound Ostomy Continence Nurs. 1997, 24, 12.
10. M.D. Nettleman, Receiver operator characteristic (ROC) curves, Infect. Control Hosp. Epidemiol. 1988, 9, 374-377.
11. S.D. Jayakar, A principal component analysis of quantitative serum protein data, Ric. Clin. Lab. 1980, 10, 243-246.
12. R. Gribonval, From projection pursuit and CART to adaptive discriminator analysis, IEEE Trans. Neural. Netw. 2005, 16, 522-532.
13. W.C. Cho, T.T. Yip, W.S. Chung, A.W. Leung, C.H. Cheng, K.K. Yue, Differential expression of proteins in the kidney, eye, aorta and serum of diabetic and non-diabetic rats, J. Cell. Biochem. 2006, 99, 256-268.
14. W. Smith, F.R. Khuri, The care of the lung cancer patient in the 21st century: a new age, Semin. Oncol. 2004, 31, 11-15.
15. Y. Tomizawa, H. Iijima, N. Sunaga, K. Sato, A. Takise, Y. Otani, S. Tanaka, T. Suga, R. Saito, T. Ishizuka, K. Dobashi, J.D. Minna, T. Nakajima, M. Mori, Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer, Clin. Cancer Res. 2005, 11, 6816-6822.